Biopharmaceutical company Ziopharm Oncology (ZIOP -5.5%) says it plans to sell an undisclosed number of shares of common stock to fund the development of its drug candidates, as well as for general corporate and working capital purposes.
Biopharmaceutical company Ziopharm Oncology (ZIOP -5.5%) says it plans to sell an undisclosed...
From other sites
Video at CNBC.com (May 18, 2016)
at CNBC.com (Jan 16, 2015)
at CNBC.com (Feb 14, 2013)
at CNBC.com (Jul 20, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs